Japan's Sosei Keeps Pharma Deals Churning With $400M Buy
Japanese drugmaker Sosei Group Corp. said Monday it would pay as much as $400 million for a venture-backed British company with several promising treatments in its pipeline, yet another signal the...To view the full article, register now.
Already a subscriber? Click here to view full article